CEO/CSO
EpiVax, Inc.
Annie De Groot has served as Chief Executive Officer and Chief Scientific Officer of the biotech company EpiVax for the past 22 years. She is a graduate of University of Chicago and Smith College, trained in Infectious Disease at New England Medical Center and Vaccines and Immunology at the National Institutes of Health, and is the author of 200 publications and 46 patents. In addition to engaging in a wide range of research at EpiVax, Brown, URI and University of Georgia, she maintains an active role in two not-for-profits, Clinica Esperanza and GAIA Vaccine Foundation.